SON.HO.UN.ADR 1/5 SF -05 (F:PHBA) — Market Cap & Net Worth
Market Cap & Net Worth: SON.HO.UN.ADR 1/5 SF -05 (PHBA)
SON.HO.UN.ADR 1/5 SF -05 (F:PHBA) has a market capitalization of $12.25 Billion (€10.48 Billion) as of September 16, 2026. Listed on the F stock exchange, this Germany-based company holds position #1899 globally and #398 in its home market, demonstrating a -4.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SON.HO.UN.ADR 1/5 SF -05's stock price €37.80 by its total outstanding shares 298053330 (298.05 Million). Also see PHBA total asset value for a full breakdown of the balance sheet.
SON.HO.UN.ADR 1/5 SF -05 Market Cap History: 2015 to 2026
SON.HO.UN.ADR 1/5 SF -05's market capitalization history from 2015 to 2026. Data shows growth from $7.07 Billion to $16.59 Billion (5.79% CAGR). Also see PHBA cash generation efficiency for how efficiently the company converts equity into cash flow.
SON.HO.UN.ADR 1/5 SF -05 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SON.HO.UN.ADR 1/5 SF -05's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check PHBA share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.91x
SON.HO.UN.ADR 1/5 SF -05's market cap is 3.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
27.98x
SON.HO.UN.ADR 1/5 SF -05's market cap is 27.98 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $14.77 Billion | $3.36 Billion | $649.00 Million | 4.39x | 22.76x |
| 2023 | $20.56 Billion | $3.74 Billion | $647.50 Million | 5.50x | 31.75x |
| 2024 | $21.78 Billion | $3.63 Billion | $601.00 Million | 6.00x | 36.24x |
| 2025 | $15.12 Billion | $3.87 Billion | $540.50 Million | 3.91x | 27.98x |
Competitor Companies of PHBA by Market Capitalization
Companies near SON.HO.UN.ADR 1/5 SF -05 in the global market cap rankings as of September 16, 2026. Review PHBA intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to SON.HO.UN.ADR 1/5 SF -05 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
SON.HO.UN.ADR 1/5 SF -05 Historical Marketcap From 2015 to 2026
Between 2015 and today, SON.HO.UN.ADR 1/5 SF -05's market cap moved from $7.07 Billion to $ 16.59 Billion, with a yearly change of 5.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €16.59 Billion | +9.68% |
| 2025 | €15.12 Billion | -30.56% |
| 2024 | €21.78 Billion | +5.92% |
| 2023 | €20.56 Billion | +39.21% |
| 2022 | €14.77 Billion | -34.78% |
| 2021 | €22.65 Billion | +65.76% |
| 2020 | €13.66 Billion | +4.56% |
| 2019 | €13.07 Billion | +46.61% |
| 2018 | €8.91 Billion | +9.46% |
| 2017 | €8.14 Billion | +15.48% |
| 2016 | €7.05 Billion | -0.21% |
| 2015 | €7.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of SON.HO.UN.ADR 1/5 SF -05 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.25 Billion USD |
| MoneyControl | $12.25 Billion USD |
| MarketWatch | $12.25 Billion USD |
| marketcap.company | $12.25 Billion USD |
| Reuters | $12.25 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SON.HO.UN.ADR 1/5 SF -05
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hea… Read more